Pharsight

Zealand Pharma patents expiration

1. Zegalogue patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US10442847 ZEALAND PHARMA Glucagon analogues
Feb, 2035

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Mar 22, 2026

Drugs and Companies using DASIGLUCAGON HYDROCHLORIDE ingredient

NCE-1 date: 2025-03-22

Market Authorisation Date: 22 March, 2021

Treatment: NA

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

ZEGALOGUE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic